How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,785 results for

Mycosis Fungoides

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

141. Concomitant B Hairy Cell Leukemia and Mycosis Fungoides in an Elderly Man Full Text available with Trip Pro

Concomitant B Hairy Cell Leukemia and Mycosis Fungoides in an Elderly Man The development of both a T- and B-cell lymphoproliferative disorder in one patient is an unlikely coincidence due to the low prevalence of each malignancy. We report a 65-year-old man with a previously documented history of B hairy cell leukemia, who presented with a new-onset acneiform eruption of his scalp, face, trunk, back, and extremities. Routine pathology of the skin lesions with immunohistochemical stains (...) and molecular studies were consistent with a folliculotropic mycosis fungoides. B hairy cell leukemia and mycosis fungoides occurring in the same patient seems to be a rare phenomenon with only 5 cases reported in the literature.

2017 Case reports in dermatology

142. PUVA Induced Bullous Pemphigoid in a Patient with Mycosis Fungoides Full Text available with Trip Pro

PUVA Induced Bullous Pemphigoid in a Patient with Mycosis Fungoides Background. Bullous pemphigoid is an autoimmune subepidermal blistering skin disease in which autoantibodies are directed against components of the basement membrane. The disease primarily affects the elderly people and in most of the patients inducing factors cannot be identified. Herein, we report a case of BP that occurred in a patient who was receiving PUVA therapy for the treatment of mycosis fungoides. Main Observation (...) . A 26-year-old woman with mycosis fungoides developed blisters while receiving PUVA therapy. On physical examination tense bullae on the normal skin, remnants of blisters, and erosions were observed on her breasts, the chest wall, and the upper abdomen. Histopathological investigations revealed subepidermal blisters with eosinophilic infiltration and in direct immunofluorescence examination linear deposition of IgG along the basement membrane zone was observed. The diagnosis of bullous pemphigoid

2017 Case reports in dermatological medicine

143. Syringotropic Mycosis Fungoides: A Rare Form of Cutaneous T-cell Lymphoma Enabling a Histopathologic “Sigh of Relief” Full Text available with Trip Pro

Syringotropic Mycosis Fungoides: A Rare Form of Cutaneous T-cell Lymphoma Enabling a Histopathologic “Sigh of Relief” Syringotropic mycosis fungoides (STMF) is a very rare variant of cutaneous T-cell lymphoma. It follows a much milder disease course than its clinically indistinguishable adnexal counterpart, folliculotropic mycosis fungoides (FMF). We report a case of a 36-year-old man who presented with erythematous, studded papules and plaques on the left upper extremity and right anterior (...) thigh diagnosed as mycosis fungoides (MF) Stage 1A on initial superficial shave biopsy. Lesions recurred after initial improvement with narrow-band ultraviolet light therapy demonstrating a concentration of abnormal lymphocytes around eccrine sweat glands on repeat biopsy consistent with STMF. Although the deeper, periadnexal infiltrate found in both STMF and FMF confers increased resistance to skin-directed therapies effective in classic MF, these entities diverge with respect to their clinical

2017 The American Journal of dermatopathology

144. Clinical outcome and prognosis of young patients with mycosis fungoides Full Text available with Trip Pro

Clinical outcome and prognosis of young patients with mycosis fungoides Mycosis fungoides (MF) in young patients is rare and may have atypical presentations. There are limited data in these patients. The objective was to determine the clinical outcome and prognosis of young patients with MF.A search of our institutional cancer registry database was conducted for patients diagnosed with MF at younger than 30 years of age.Our study included 74 patients (median age at diagnosis 25.5 yrs). Sixty

2017 Pediatric dermatology

145. Analysis of CTCL cell lines reveals important differences between mycosis fungoides/Sézary syndrome vs. HTLV-1+ leukemic cell lines Full Text available with Trip Pro

Analysis of CTCL cell lines reveals important differences between mycosis fungoides/Sézary syndrome vs. HTLV-1+ leukemic cell lines HTLV-1 is estimated to affect ~20 million people worldwide and in ~5% of carriers it produces Adult T-Cell Leukemia/Lymphoma (ATLL), which can often masquerade and present with classic erythematous pruritic patches and plaques that are typically seen in Mycosis Fungoides (MF) and Sézary Syndrome (SS), the most recognized variants of Cutaneous T-Cell Lymphomas

2017 Oncotarget

146. Tissue and serum lipidome shows altered lipid composition with diagnostic potential in mycosis fungoides Full Text available with Trip Pro

Tissue and serum lipidome shows altered lipid composition with diagnostic potential in mycosis fungoides Mycosis fungoides (MF) is the most common type of cutaneous T cell lymphoma. In this study, we used matrix-assisted laser desorption/ionization-Fourier transform ion cyclotron resonance mass spectrometry (MALDI-FTICR-MS) to perform lipidomic profiling of 5 MF tissue samples and 44 serum samples (22 from MF patients and 22 from control subjects). Multivariate statistical analysis of the mass

2017 Oncotarget

147. Langerhans cell histiocytosis followed by folliculotropic mycosis fungoides Full Text available with Trip Pro

Langerhans cell histiocytosis followed by folliculotropic mycosis fungoides 28670259 2018 11 13 1642-395X 34 3 2017 Jun Postepy dermatologii i alergologii Postepy Dermatol Alergol Langerhans cell histiocytosis followed by folliculotropic mycosis fungoides. 273-275 10.5114/pdia.2017.67055 Błażewicz Izabela I Department of Dermatology, Venereology and Allergology, Medical University of Gdansk, Gdansk, Poland. Sokołowska-Wojdyło Małgorzata M Department of Dermatology, Venereology and Allergology

2017 Advances in Dermatology and Allergology/Postȩpy Dermatologii i Alergologii

148. Crazy-Paving Pattern Due to Herpetic Pneumonia in a Patient with Mycosis Fungoides: A Case Report Full Text available with Trip Pro

Crazy-Paving Pattern Due to Herpetic Pneumonia in a Patient with Mycosis Fungoides: A Case Report Herpetic pneumonia in immune deficient patients could be fatal if not treated. Considering the low prevalence of this disease, computed tomography (CT) scan findings of this condition are not well elucidated. This report describes the CT scan findings of a patient with immune system deficiency due to mycosis fungoides, and pneumonia caused by herpes simplex virus 1 (HSV-1). Bilateral alveolar

2017 Tanaffos

149. Eruptive Seborrheic Keratoses Restricted to Plaque/Patch-Stage Mycosis Fungoides Full Text available with Trip Pro

Eruptive Seborrheic Keratoses Restricted to Plaque/Patch-Stage Mycosis Fungoides Eruptive seborrheic keratoses (ESK) are rare in dermatology. They are usually inflammatory in nature and may be encountered as Leser-Trélat sign. ESK may also be simultaneously observed with hepatic angiomas, chemotherapy, segmental neurofibromatosis, HIV or erythrodermic pityriasis rubra pilaris, psoriasis, and drug eruption. ESK may be transient and self-healing. Others recede after successful treatment (...) of the underlying disease. In some instances, seborrheic keratoses may follow an isotopic response and remain strictly restricted to sites of previous eczema, photo-exposition or tattoos. A patient with patch/plaque lesions of classic-type mycosis fungoides (MF) presented sudden ESK that were exclusively limited to the MF lesions. In conclusion, this patient combined an isotopic response and ESK.

2017 Case reports in dermatology

150. A possible association between mycosis fungoides and Muir-Torre syndrome: Two disorders with microsatellite instability Full Text available with Trip Pro

A possible association between mycosis fungoides and Muir-Torre syndrome: Two disorders with microsatellite instability 28761921 2019 02 26 2352-5126 3 4 2017 Jul JAAD case reports JAAD Case Rep A possible association between mycosis fungoides and Muir-Torre syndrome: Two disorders with microsatellite instability. 358-361 10.1016/j.jdcr.2017.04.007 Lewis Daniel J DJ School of Medicine, Baylor College of Medicine, Houston, Texas. Department of Dermatology, The University of Texas MD Anderson (...) Cancer Center, Houston, Texas. Duvic Madeleine M Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas. eng Case Reports 2017 07 20 United States JAAD Case Rep 101665210 2352-5126 ECP, extracorporeal photopheresis HNPCC, hereditary nonpolyposis colorectal carcinoma ICL, interstrand crosslink Lynch syndrome MF, mycosis fungoides MLH1 MMR, mismatch repair MSH2 MSI, microsatellite instability MSI-H, high levels of microsatellite instability MTS, Muir-Torre syndrome

2017 JAAD Case Reports

151. Large Cell Transformation of Oral Mycosis Fungoides Full Text available with Trip Pro

Large Cell Transformation of Oral Mycosis Fungoides Mycosis fungoides (MF) accounts for approximately 50% of all primary cutaneous lymphomas. MF occurrence in the oral cavity is extremely rare with approximately 45 cases reported to date. We present a case of a 68 year-old man with a raised nodular lesion of the ventral tongue with clinical impression of irritational fibroma. Histopathologic and immunohistochemical (IHC) examination revealed a phenotype consistent with MF with large cell

2017 Head and neck pathology

152. Mycosis fungoides presenting as symmetric concentric patches mimicking figurate erythema Full Text available with Trip Pro

Mycosis fungoides presenting as symmetric concentric patches mimicking figurate erythema 28702497 2019 02 26 2352-5126 3 4 2017 Jul JAAD case reports JAAD Case Rep Mycosis fungoides presenting as symmetric concentric patches mimicking figurate erythema. 288-290 10.1016/j.jdcr.2017.03.013 Notay Manisha M Department of Dermatology, University of California Davis, Sacramento, California. Petukhova Tatyana A TA Department of Dermatology, University of California Davis, Sacramento, California. Kiuru (...) 101665210 2352-5126 EAC, erythema annulare centrifugum MF, mycosis fungoides Mycosis fungoides T-cell receptor gene rearrangement TCR, T-cell receptor biopsy cutaneous T-cell lymphoma figurate erythema polymerase chain reaction 2017 7 14 6 0 2017 7 14 6 0 2017 7 14 6 1 epublish 28702497 10.1016/j.jdcr.2017.03.013 S2352-5126(17)30076-0 PMC5484965 Br J Dermatol. 2009 Jan;160(1):119-26 18721189 Blood. 2005 May 15;105(10):3768-85 15692063 J Am Acad Dermatol. 2014 Feb;70(2):205.e1-16; quiz 221-2 24438969

2017 JAAD Case Reports

153. Donor-derived mycosis fungoides following reduced intensity haematopoietic stem cell transplantation from a matched unrelated donor Full Text available with Trip Pro

Donor-derived mycosis fungoides following reduced intensity haematopoietic stem cell transplantation from a matched unrelated donor A 46-year-old woman with a history of dasatinib-resistant chronic myeloid leukaemia, clonal evolution and monosomy 7 underwent reduced intensity conditioned in vivo T-cell-depleted allogeneic haematopoietic stem cell transplantation (HSCT) from a matched unrelated donor. Following the transplantation, she developed recurrent cutaneous graft versus host disease (...) (GvHD), which required treatment with systemic immunosuppression and electrocorporeal photophoresis. Concurrently, she developed a lichenoid rash with granulomatous features suggestive of cutaneous sarcoidosis. Additional treatment with hydroxychloroquine was initially successful, but 2 months later, she developed erythroderma with palpable lymphadenopathy. Repeated histological analysis established a diagnosis of folliculotropic mycosis fungoides stage IVA2, and the malignant clone was confirmed

2017 BMJ case reports

154. Immunohistopathological Study of c-FLIP Protein in Mycosis Fungoides Full Text available with Trip Pro

Immunohistopathological Study of c-FLIP Protein in Mycosis Fungoides Background: Mycosis fungoides (MF) is the commonest variant of primary cutaneous T cell lymphoma with several clinicopathologic variants. Defective apoptotic mechanism may be important in the pathogenesis and progression of MF. c-FLIP protein is an important anti-apoptotic marker and chemotherapeutic resistant factor. This study aimed to evaluate the c-FLIP expression in MF and its role in the pathogenesis of MF. Methods

2017 Asian Pacific journal of cancer prevention : APJCP

155. An adolescent with granulomatous mycosis fungoides infiltrating skeletal muscle successfully treated with oral prednisone Full Text available with Trip Pro

An adolescent with granulomatous mycosis fungoides infiltrating skeletal muscle successfully treated with oral prednisone 28653029 2019 02 26 2352-5126 3 4 2017 Jul JAAD case reports JAAD Case Rep An adolescent with granulomatous mycosis fungoides infiltrating skeletal muscle successfully treated with oral prednisone. 276-279 10.1016/j.jdcr.2017.03.001 Lewis Daniel J DJ School of Medicine, Baylor College of Medicine, Houston, Texas. Department of Dermatology, University of Texas MD Anderson (...) of Pediatric Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas. Kim Youn H YH Department of Dermatology, Stanford University, Stanford, California. Duvic Madeleine M Department of Dermatology, University of Texas MD Anderson Cancer Center, Houston, Texas. eng Case Reports 2017 06 15 United States JAAD Case Rep 101665210 2352-5126 BSA, body surface area CT, computed tomography GMF, granulomatous mycosis fungoides MF, mycosis fungoides PET, positron emission tomography granulomatous

2017 JAAD Case Reports

156. A Trial Assessing the Effect of Pembrolizumab Combined With Radiotherapy in Patients With Relapsed, Refractory, Specified Stages of Cutaneous T-cell Lymphoma (CTCL) Mycosis Fungoides (MF)/Sezary Syndrome (SS)

A Trial Assessing the Effect of Pembrolizumab Combined With Radiotherapy in Patients With Relapsed, Refractory, Specified Stages of Cutaneous T-cell Lymphoma (CTCL) Mycosis Fungoides (MF)/Sezary Syndrome (SS) A Trial Assessing the Effect of Pembrolizumab Combined With Radiotherapy in Patients With Relapsed, Refractory, Specified Stages of Cutaneous T-cell Lymphoma (CTCL) Mycosis Fungoides (MF)/Sezary Syndrome (SS) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record (...) managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. A Trial Assessing the Effect of Pembrolizumab Combined With Radiotherapy in Patients With Relapsed, Refractory, Specified Stages of Cutaneous T-cell Lymphoma (CTCL) Mycosis Fungoides (MF)/Sezary Syndrome (SS) (PORT) The safety

2017 Clinical Trials

157. Photodynamic Therapy in Treating Patients With Refractory Mycosis Fungoides

Photodynamic Therapy in Treating Patients With Refractory Mycosis Fungoides Photodynamic Therapy in Treating Patients With Refractory Mycosis Fungoides - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more (...) . Photodynamic Therapy in Treating Patients With Refractory Mycosis Fungoides The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03281811 Recruitment Status : Recruiting First Posted : September 13, 2017 Last Update Posted : November

2017 Clinical Trials

158. Low Dose Total Skin Electron Beam Radiation Therapy and Mechlorethamine Hydrochloride Gel in Treating Patients With Mycosis Fungoides

Low Dose Total Skin Electron Beam Radiation Therapy and Mechlorethamine Hydrochloride Gel in Treating Patients With Mycosis Fungoides Low Dose Total Skin Electron Beam Radiation Therapy and Mechlorethamine Hydrochloride Gel in Treating Patients With Mycosis Fungoides - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You (...) have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Low Dose Total Skin Electron Beam Radiation Therapy and Mechlorethamine Hydrochloride Gel in Treating Patients With Mycosis Fungoides The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03288818

2017 Clinical Trials

159. Pembrolizumab and Interferon Gamma-1b in Treating Patients With Stage IB-IVB Relapsed or Refractory Mycosis Fungoides and Sezary Syndrome

Pembrolizumab and Interferon Gamma-1b in Treating Patients With Stage IB-IVB Relapsed or Refractory Mycosis Fungoides and Sezary Syndrome Pembrolizumab and Interferon Gamma-1b in Treating Patients With Stage IB-IVB Relapsed or Refractory Mycosis Fungoides and Sezary Syndrome - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study (...) Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Pembrolizumab and Interferon Gamma-1b in Treating Patients With Stage IB-IVB Relapsed or Refractory Mycosis Fungoides and Sezary Syndrome The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care

2017 Clinical Trials

160. Toll-like receptor (TLR)7 expression in mycosis fungoides and psoriasis: a case-control study. (Abstract)

Toll-like receptor (TLR)7 expression in mycosis fungoides and psoriasis: a case-control study. Toll-like receptors (TLRs) have been implicated in various dermatological diseases. TLR agonists have the capacity to potently activate the innate immune cells of patients with advanced, refractory, cutaneous T-cell lymphoma (CTCL).To detect TLR7 gene expression in mycosis fungoides (MF) (a neoplastic skin condition) and to compare it with psoriasis (an inflammatory skin condition) in an attempt

2017 Clinical & Experimental Dermatology

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>